Sunshine Biopharma (SBFM) Gross Margin Growth (3y) (2021 - 2026)
Sunshine Biopharma (SBFM) Gross Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 567.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -100.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -196.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -228.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 12.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -61.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Sunshine Biopharma | 1.58 Mn | -12.17 Mn | 2.43 Mn | -892.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -892.00 |
| Mar 31, 2026 | -1,039.00 |
| Dec 31, 2025 | -253.00 |
| Sep 30, 2025 | -1,783.00 |
| Jun 30, 2025 | -1,394.00 |
| Mar 31, 2025 | -2,053.00 |
| Dec 31, 2024 | 424.00 |
| Sep 30, 2024 | -2,730.00 |
| Jun 30, 2024 | -3,966.00 |
| Mar 31, 2024 | -2,255.00 |
| Dec 31, 2023 | -2,921.00 |
| Sep 30, 2023 | -2,963.00 |
| Jun 30, 2023 | -3,081.00 |
| Mar 31, 2023 | -2,767.00 |
| Sep 30, 2022 | -46,280.00 |
| Jun 30, 2022 | -118,945.00 |
| Mar 31, 2022 | -1.82 Mn |
| Mar 31, 2021 | 6,435.00 |